Moderna, Inc. (ETR:0QF)
27.98
-1.99 (-6.64%)
Dec 23, 2025, 4:00 PM EST
Moderna Revenue
Moderna had revenue of $1.02B USD in the quarter ending September 30, 2025, a decrease of -45.44%. This brings the company's revenue in the last twelve months to $2.23B, down -56.07% year-over-year. In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%.
Revenue (ttm)
$2.23B
Revenue Growth
-56.07%
P/S Ratio
5.45
Revenue / Employee
$384.83K
Employees
5,800
Market Cap
10.36B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
| Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
| Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
| Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
| Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
| Dec 31, 2019 | 60.00M | -75.07M | -55.58% |
| Dec 31, 2018 | 135.07M | -70.76M | -34.38% |
| Dec 31, 2017 | 205.83M | 97.43M | 89.88% |
| Dec 31, 2016 | 108.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |
Moderna News
- 3 days ago - Moderna (MRNA) Stock Dips While Market Gains: Key Facts - Nasdaq
- 3 days ago - Moderna: Why I Am Selling The 'Relief Rally' - Seeking Alpha
- 5 days ago - Rivian, Sandisk, And Moderna Are Among the Top 10 Large-Cap Gainers Last Week (Dec. 15-Dec. 19): Are the Others in Your Portfolio? - Benzinga
- 7 days ago - MRNA to Get CEPI Funding for Phase III Study on Pandemic Influenza Jab - Nasdaq
- 7 days ago - Down 80%, Should You Buy the Dip on Moderna? - The Motley Fool
- 8 days ago - Noteworthy Thursday Option Activity: AVGO, MRNA, IBM - Nasdaq
- 8 days ago - Moderna's $54M Lifeline: Bird Flu Bet Revived After U.S. Pullback - GuruFocus
- 8 days ago - Moderna (MRNA) Secures $54.3M Funding for Bird Flu Vaccine Trial - GuruFocus